| HCV regimen | Number (%) of patients |
|---|---|
| Sofosbuvir/ledipasvir +/- ribavirin | 558 (57) |
| Sofosbuvir/daclatasvir +/- ribavirin | 136 (14) |
| Sofosbuvir/pegIFN/ribavirin | 109 (11) |
| Ombitasvir/paritaprevir/ritonavir/dasabuvir+/-ribavirin | 104 (10) |
| Sofosbuvir + ribavirin | 45 (5) |
| Ombitasvir/paritaprevir/ritonavir +/- ribavirin | 20 (2) |
| Simeprevir +pegIFN + ribavirin | 3 (1) |